We use our own and third party cookies to offer you our services, customize and analyze your browsing and show you advertising related to your preferences. By continuing to browse, we consider that you accept its use. You can change the settings and get more information in the
Median survival after diagnosis of patients with idiopathic pulmonary arterial hypertension is 2.8 years without any treatment. The leading causes of death are right heart failure (63%), sudden death (7%) and infections such as pneumonia (7%).
On the other hand, good treatment follow-up ensures a better evolution of the disease, which is why the patient should commit to the therapy and be aware of the medications to take, as well as their dosage and adverse effects. Follow-up requires a multidisciplinary team at the referral centre and good coordination with the local unit or primary care.
The main complications of drug treatment are:
Endothelin receptor antagonists. Alteration of liver enzymes, fluid retention and risk of hypotension (low blood pressure).
Phosphodiesterase-5 inhibitors. Headaches and discomfort in the pit of the stomach in the form of gastritis (inflammation).
Parenteral prostanoids (injected, not oral). According to the administration system, the main adverse effects are related to the malfunction, infection or obstruction of the catheter. For iloprost, coughing is the main effect related to inhalation. For treprostinil, pain at the infusion site may cause treatment to be discontinued.
Heart failure is often an acute complication. The right side of the heart in a patient with pulmonary hypertension increases in size and becomes insufficient to pump blood to the lungs. To compensate for this and increase the blood flow, the heart increases the size of the walls of the right ventricle and the right atrium. This overload, however, is a temporary measure, because it can end up causing the heart to fail.
Sudden symptoms of heart failure can be due to increased physical activity, increased fluid and salt intake, fever, infections, anaemia, irregular heartbeats (arrhythmias), overactive thyroid gland and even kidney disease.
The main chronic complication of pulmonary hypertension is heart failure. The disease has no cure, but many episodes of heart failure can be controlled with medication and the correction of the disorder producing it. It can turn into a chronic disease and become worse with infections or other factors.
Cardiac function can also worsen if the person stops taking the medications needed to control the underlying disease, or due to the natural progression of the disease.
Sorry this content wasn't helpful to you. Send us your comment and we will take it into account to continue improving.
Thanks for your help!
An error has occurred and we were unable to send your opinion, please try again later.
Substantiated information by:
Isabel Blanco Vich
Joan A. Barberà Mir
Published: 23 November 2021
Updated: 1 December 2021
The donations that can be done through this webpage are exclusively for the benefit of Hospital Clínic of Barcelona through Fundació Clínic per a la Recerca Biomèdica and not for BBVA Foundation, entity that collaborates with the project of PortalClínic.
Receive the latest updates related to this content.
Thank you for subscribing!
If this is the first time you subscribe you will receive a confirmation email, check your inbox
An error occurred and we were unable to send your data, please try again later.